Hernández RH, Hernández SJR, Ramos LM, Padilla GCM

Language: Spanish
References: 17
Page: 1-16
PDF size: 337.09 Kb.

ABSTRACT

Objective: Evaluate the cost of simultaneous bilateral phacoemulsification cataract surgery vs. sequential bilateral phacoemulsification with intraocular lens implantation.
Methods: An analytic economic evaluation was conducted of 762 patients aged over 50 years undergoing simultaneous bilateral phacoemulsification cataract surgery and 762 patients undergoing sequential bilateral phacoemulsification cataract surgery at Ramón Pando Ferrer Cuban Institute of Ophthalmology in the period 2014-2019. Evaluation was performed of costs incurred on human resources and materials, indirect costs, and total costs for the two groups after surgery, starting from the scientific certainty that both procedures are equally effective.
Results: The 61-80 years age group and female sex (75 %) prevailed in both groups. Human resources unit costs decreased 1.69 CUP in group I, whereas material resources total and unit costs were similar in both groups. Indirect unit costs decreased 3.63 CUP in group I. Total unit cost was 6.19 CUP lower in the simultaneous bilateral surgery group than in the sequential bilateral surgery group.
Conclusions: Simultaneous bilateral phacoemulsification cataract surgery is more cost-effective than sequential bilateral phacoemulsification.

REFERENCES

1. MINSAP. Anuario Estadístico de Salud; 2017 [acceso: 20/12/2018]. Disponible en: http://bvscuba.sld.cu/anuario- estadístico- de- cuba/

2. Bourne RRA, Flaxman SR, Braithwaite T, Cicinelli MV, Das A, Jonas JB, et al. Vision Loss Expert Group. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(9):e888-97.

3. Fricke TR, Tahhan N, Resnikoff S, Papas E, Burnett A, Suit MH, Naduvilath T, Naidoo K. Global prevalence of presbyopia and vision impairment from uncorrected presbyopia: Systematic review, meta-analysis, and modelling. Ophthalmology. 2018;125(10):1492-9.

4. World Health Organization. Global data on visual impairment. 2010. Geneva: WHO; 2012 [acceso: 20/12/2018]. Disponible en: http://www.who.int/blindness/GLOBAL DATAFINALforweb.pdf

5. Jiménez Corona A, Graue Hernández EO. Discapacidad visual y ceguera: impacto en la calidad de vida y costos. México: Escuela de Salud Pública de México; 2015 [acceso: 20/12/2018]. Disponible en: http://www.espm.mx/avisos/454-discapacidad-visual-calidad-vida.html

6. Badía X, Rovira J. Evaluación Económica de Medicamentos. Un instrumento para la toma de decisiones en la práctica clínica y la política sanitaria. Málaga, España: Editorial Luzan; 1994.

7. Drummond MF. Métodos para la evaluación económica de los programas de Asistencia Sanitaria. Madrid: Ediciones Díaz de Santos; 2001:11-4.

8. Gálvez González AM. Guía Metodológica para la Evaluación Económica en Salud. La Habana: Ministerio de salud Pública; 2003:7-13.

9. Minassian DC, Rosen P, Dart JKG, Reidy A, Desai P, Sidhu M. Extracapsular cataract extraction compared with small incision surgery by phacoemulsification: a randomised trial. Brit J Opthalmol. 2001;85:822-9.

10. Arumugam G, Cheen Yeng L, Kandiah M, Azmi S, Teck Onn L. Economic evaluation of MOH Ophthalmology services. Malaysia: Ministry Of Health Ophthalmic Services; 2001.

11. Leivo T, Sarikkola AU, Uusitalo RJ, Hellstedt T, Ess SL, Kivelä T. Simultaneous bilateral cataract surgery: economic analysis; Helsinki Simultaneous Bilateral Cataract Surgery Study Report 2. J Cataract Refract Surg. 2011;37(6):1003-8. doi: 10.1016/j.jcrs.2010.12.050

12. Javitt JC, Steinberg EP, Sharkey P, Schein OD, Tielsch JM, Diener M, Legro M, Sommer A. Cataract surgery in one eye or both. A billion dollar per year issue. Ophthalmology. 1995;102(11):1583-92.

13. Chylack LT Jr, Wolfe JK, Singer DM. The lens opacities classification system III; the longitudinal study of Cataract Study Group. Arch Optalmol. 1993;111:831-6.

14. Robinson R. Costs and cost-minimisation analysis. BMJ. 1993;307:726-8.

15. American Society of Cataract and Refractive Surgery (ASCRS). Encuesta. ASCRS; 2014.

16. Gobierno de España. Seguridad, efectividad y coste-efectividad de la cirugía de cataratas bilateral y simultánea frente a la cirugía bilateral de cataratas en dos tiempos. España: Informe de Evaluación de Tecnologías Sanitarias del Gobierno de España; 2006.

17. Sloan W, Rush MD, Ashley E, Gerald MA, Jason C, Smith BA, et al. Prospective analysis of outcomes and economic factors of same-day bilateral cataract surgery in the United States. J Cat Refract Surg. 2015;41:732-9.